Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

1 records in Main database · 1 strong · 1 status checked

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	Rincell-1 by Rinri Therapeutics	Rinri Therapeutics	Therapeutic	-	Cell Therapy	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 1	92%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+2

Rinri Therapeutics · Cell Therapy · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing LossAuditory Neuropathy

Population

AdultAge-RelatedAuditory Neuropathy